RECTAL EA2201
Study #EA2201A Phase II Study of Neoadjuvant Nivolumab plus Ipilimumab and Short-Course Radiation in MSI-H / dMMR Locally Advanced Rectal Adenocarcinoma
Back To Clinical Trials NCI Database Entry
A Phase II Study of Neoadjuvant Nivolumab plus Ipilimumab and Short-Course Radiation in MSI-H / dMMR Locally Advanced Rectal Adenocarcinoma
Back To Clinical Trials NCI Database Entry